JAK Inhibition May Improve Multiple Autoimmune Conditions in People with Down Syndrome
The Dermatology Digest
AUGUST 13, 2024
Drawing upon their 2016 discovery that the interferon response is constantly activated in people with Down syndrome, researchers designed the trial to focus on the autoimmune and inflammatory skin conditions that are common in people with Down syndrome including alopecia areata, psoriasis, atopic dermatitis, and hidradenitis suppurativa.
Let's personalize your content